Bonnie Leung

8PUBLICATIONS
17CO-AUTHORS
Deep learningCounselling psychologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 25, 2025
Enhanced Lung Cancer Survival Prediction Using Semi-Supervised Pseudo-Labeling and Learning from Diverse PET/CT Datasets.

Mohammad R Salmanpour, Arman Gorji, Amin Mousavi

|Apr 08, 2024
Predicting which patients with cancer will see a psychiatrist or counsellor from their initial oncology consultation document using natural language processing.

John-Jose Nunez, Bonnie Leung, Cheryl Ho

|Aug 25, 2023
Beyond PACIFIC: Real-World Outcomes of Adjuvant Durvalumab According to Treatment Received and PD-L1 Expression.

Marie-Hélène Denault, Jamie Feng, Shelley Kuang

|Jun 27, 2023
Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic Therapy.

Rebekah Rittberg, Bonnie Leung, Aria Shokoohi

|Dec 22, 2022
Real World Patient Eligibility for Second Line Lurbinectedin Based Treatment in Small Cell Lung Cancer: Understanding Epidemiology and Estimating Health Care Utilization.

Rebekah Rittberg, Bonnie Leung, Zamzam Al-Hashami

|Nov 24, 2022
Alternate Pembrolizumab Dosing Interval in Advanced NSCLC with PD-L1 TPS ≥ 50%: 3 Weekly Compared to 6 Weekly Dosing.

Lauren Jones, Rebekah Rittberg, Bonnie Leung

Pageof 2

Frequent Collaborators

5 joint publications

Cheryl Ho

3 joint publications

Selina Wong

3 joint publications

Rebekah Rittberg

3 joint publications

Aria Shokoohi